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Abstract
Background: The term ichthyosis describes a generalized disorder of cornification characterized by scaling and/or
hyperkeratosis of different skin regions. Mutations in a broad group of genes related to keratinocyte differentiation
and epidermal barrier function have been demonstrated to play a causative role in disease development. Ichthyosis
may be classified in syndromic or non-syndromic forms based on the occurrence or absence of extracutaneous signs.
In this setting, the diagnosis of ichthyosis is an integrated multistep process requiring a multidisciplinary approach in
order to formulate the appropriate diagnostic hypothesis and to address the genetic testing.
Methods: Due to the complex features of the different ichthyoses and the high number of genes involved we have
investigated a group of 64 patients, affected by syndromic and non-syndromic diseases, using Next Generation
Sequencing as a new tool for the molecular diagnosis.
Results: Using this innovative molecular approach we were able to find pathogenic mutations in 53 out of 64 patients
resulting in 82.8 % total detection rate. An interesting result from the analysis of the data is the high rate of novel
sequence variations found compared to known mutations and the relevant rate of homozygous mutations.
Conclusions: The possibility to analyze a large number of genes associated with various diseases allows to study
cases with phenotypes not well-determined, giving the opportunity to make new genotype-phenotype correlation. In
some cases there were discrepancies between clinical features and histology or electron microscopy and only molecular
analysis allowed to definitively resolve the diagnostic dilemma. The genetic diagnosis of ichthyosis leads to a more
accurate and effective genetic counseling, allowing correct evaluation of the risk of recurrence, particularly in families
with consanguineous background.
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Background
The ichthyoses are a heterogeneous group of inherited
skin disorders characterized by a defect of keratinization
with the clinical appearance of scaling or hyperkeratosis
or both. The classification of Oji et al. in 2010 has di-
vided the various forms of ichthyosis in two major
groups, non-syndromic and syndromic, on the basis of
the absence or presence of extracutaneous symptoms
[1]. The latter are then classified according to the preva-
lent symptom. Specifically, there are forms associated
with neurological involvement, hair abnormalities and,
in some cases, with fatal course. Apart, there are syn-
dromic X-linked ichthyoses and those forms that do not
fit in previous groups.
Non syndromic forms are divided in common ichthyoses
(vulgaris and X-linked), autosomal recessive congenital
ichthyosis (ARCI), keratinopathic ichthyoses and others.
ARCI is a heterogeneous group with a limited correl-
ation between genotype and phenotype, which ranges
from harlequin ichthyosis to lamellar ichthyosis (LI) and
congenital ichthyosiform erythroderma (CEI). Mutations
* Correspondence: andrea.diociaiuti@opbg.net
†Equal contributors
1Dermatology Unit, Bambino Gesù Children’s Hospital, IRCCS, Piazza S.
Onofrio 4, 00165 Rome, Italy
Full list of author information is available at the end of the article
© 2016 Diociaiuti et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Diociaiuti et al. Orphanet Journal of Rare Diseases  (2016) 11:4 
DOI 10.1186/s13023-016-0384-4
in TGM1 are responsible for 32 % of ARCI and are
strongly associated with collodion baby [2]. In this group
truncating mutations cause a more severe phenotype
compared to missense mutations [3].
The genetic basis of most ichthyosis forms has been
unraveled over the past two decades. Nevertheless, in
some patients affected by a clinically well-defined sub-
type of ichthyosis, the pathogenetic mutations cannot be
identified (22 % in ARCI) [2].
The classification based on clinical features elaborated
by the multicenter consensus [1] has been extremely
useful in order to provide a correct diagnostic approach,
to guarantee an early diagnosis and to reduce the
medical costs. Ichthyosis diagnosis requires a multidis-
ciplinary approach, coordinated by a dermatologist, in
order to correlate the clinical features, the microscopic
and laboratory data and to formulate a diagnostic
hypothesis; the final diagnosis is generally established
through molecular testing.
Currently, molecular diagnosis of congenital and syn-
dromic ichthyoses is a very hard challenge due to the
high number of genes involved. Moreover, there is a
considerable genetic heterogeneity, since multiple genes
can cause the same form of ichthyosis, and phenotypic
heterogeneity, since the same gene may cause different
forms of ichthyosis.
Sanger sequencing has been previously recognized as
the gold standard for mutation analysis in molecular
diagnosis; however, its low-throughput, long turnaround
time and overall cost [4] have called for new paradigms.
Next-Generation Sequencing (NGS) can massively
sequence millions of DNA segments, promising low
costs, increased workflow speed and enhanced sensitivity
in mutation detection [4, 5]. Based on these observations
we have planned to study a group of ichthyosis patients
by means of NGS using a large panel of genes able to
cover the mutational spectrum of most disease forms.
Our goal is to validate a multidisciplinary approach
and to improve diagnostic accuracy in patients with
ichthyosis achieving the identification of the mutation
responsible for the disease.
Methods
Patient recruitment
In this study we enrolled, from September 2013 until
December 2014, 64 patients, 34 males and 30 females
(age ranges from few months to 66 years), affected with
ichthyosis from the Pediatric Dermatology Unit and
from the Molecular Genetics Laboratory, Medical
Genetics Unit Outpatients Department of the Bambino
Gesù Children’s Hospital in Rome;. The study was
approved by Ethical committee scientific board of
Bambino Gesù Children’s Hospital and was conducted
in accordance with the Helsinki Declaration. Patients
were referred to four distinct groups: ARCI, X-linked
ichthyosis, keratinopathic ichthyosis and syndromic
forms while individuals with ichthyosis vulgaris, which is
not a rare disease, were excluded from the study. After
obtaining informed consent, blood samples were drawn
from patients for mutation search and from parents for
mutation validation and segregation analysis. Genomic
DNA was extracted from peripheral blood with Qiagen
columns (QIAamp DNA minikit; Qiagen, Hilden,
Germany) according to the manufacturer’s instructions.
Concentration and purity of DNA samples were quanti-
fied by ND-1000 spectrophotometer (NanoDrop; Thermo
Scientific, Waltham, MA, USA).
Clinico-pathological approach
Our diagnostic path first provides gathering a thorough
history specifically oriented to family history, pregnancy,
birth, and presentation of the disease. Secondly, dermato-
logical examination must consider the type (size, thickness,
colour) and distribution of scales, the presence of erosions,
the involvement of palms and soles.
In all cases, according to the history and to the clinical
appearance, we investigate possible extracutaneous
symptoms, together with other specialists when required
(pediatrician, neurologist, ophthalmologist, specialist in
metabolic disorders, and otolaryngologist).
In case of a clear clinical diagnosis of ichthyosis
vulgaris we do not proceed to further study, while all
other patients undergo skin biopsy. In particular we per-
form biopsy even in those cases that, while presenting a
phenotype compatible with the vulgaris type, show
inconsistent anamnesis or suspicion of extracutaneous
involvement.
Skin sample is subjected to light and electron
microscopy and, in selected cases, immunohisto-
chemical examination according to the suspected
diagnosis. Microscopic hair examination is performed
in case of suspicion of Netherton syndrome or
trichothiodystrophy.
When extracutaneous involvement is detected, the
organ specialists are involved in a multidisciplinary
approach in order to orientate specific laboratory tests
(fitanic acid, very-long-chain-fatty-acid, liver function
tests, creatine phosphokinase etc.) or other instrumental
examinations. Finally, the case is presented to the
geneticist with a diagnosis based on clinicopathological
findings.
In case of blood sample sent directly to our
Molecular Genetics Laboratory we ask for clinic-
pathologic information, pictures of the patient, family
history and laboratory data. All this information is
collegially discussed by the dermatologist, geneticist
and pathologist.
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NIPAL4 ID-1 1 year F No 5 yrs Brown scales, PP (+) - ARCI
ID-2 Birth M Yesa 2 yrs Scales - NA
ID-3 Birth M No 22 yrs Large brown scales, hyperkeratotic plaques - ARCI
ID-4 Birth M No 24 yrs Face erythema, Hyperkeratotic
plaques , PP (+++), ectropion,
- Keratinopathic
ichthyosis





M No 13 yrs Face erythema, large scales, PP (++) - ARCI
ID-7 Birth M No 5 yrs Erythema, thin and large scales, PP (+) - ARCI
ID-8 NA NA NA NA NA
ID-9 NA M No 72 yrs Generalized erythema, large scales - ARCI
ID-10 Birth,
collodion
F No 1 mo Fine scales, minimal erythema, PP (+),
ectropion, ear deformity
- ARCI
ID-11 NA F No 6 yrs Large and medium brownish scales - NA
ID-12 Birth,
collodion





M No 9 yrs Fine whitish scales, particularly on
the abdomen
- Undefined
CYP4F22 ID-14 NA NA NA NA NA NA NA
ID-15 Birth,
collodion
F No 1 yrs Rapid detachment of collodion and




TGM1 ID-16 NA NA NA NA NA NA NA
ID-17 Birth,
collodion
M No 16 yrs Large brownish scales, erythema on




F No 3 yrs Small whitish scales, PP (+), ectropion - ARCI
ID-19 Birth,
collodion
F No 4 mos Scales - NA
ID-20 Birth,
collodion
F No 7 mos Large brownish scales, onychodystrophy,




M Nob 1 yr Brownish large scales, slight erythema,








ALOXE3 ID-23 Birth M No 1 yr Fine small scales - ARCI
ID-24 Birth,
collodion
M No 3 yrs Small thin scales, PP (++), ectropion,
eclabion, ear deformity
- ARCI
ABCA12 ID-25 Birth M Nob 15 yrs Harlequin ichthyosis NA NA
ID-26 NA F No 6 yrs NA NA A
ID-27 NA F NA 36 yrs NA NA NA
/ ID-28 3
months
F No 5 yrs Small whitish scales - ARCI
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Genetic investigations: Targeted re-sequencing
Targeted resequencing was performed with a uniquely
customized design: TruSeq® Custom Amplicon (Illumina,
San Diego, CA) using the MiSeq® sequencing platform
(Illumina). TruSeq Custom Amplicon (TSCA) is a fully
integrated end-to-end amplicon sequencing solution,
including online probe design and ordering through the
Illumina website, assay, sequencing, automated data ana-
lysis and offline software for reviewing results. Online
probe design was performed by entering into the Design
Studio (DS) software (Illumina) the target genomic
regions. DS is a personalized, easy-to-use, web-based
sequencing assay design tool that enables to move from
project initiation to design, review, and ordering. DS
provides dynamic feedback to optimize target region
coverage, reducing the time required to design custom
projects. Once the design is completed, a list of amplicons
(short regions of DNA covering the full target region) is
visualized and their quality is assessed on the basis of the
predicted amplicon score provided by DS. The amplicon
score is an estimate of the relative performance of a
particular amplicon compared to all others in the pool. DS
returns only candidate amplicons that are predicted to
work well in the multiplex TruSeq Custom Amplicon
assay. TSCA kit produces the required targeted amplicons
with the necessary adapters and indices for sequencing on
Table 1 Clinicopathological findings in autosomal recessive congenital ichthyosis (ARCI) patient group (Continued)
/ ID-29 Birth M No 38 yrs Erythema, brownish scales, onychodystrophy,
PP (++)
- NA
/ ID-30 Birth F No 26 yrs Large scales - NA
/ ID-31 Birth F NAd 1 yr Erythroderma, large whitish scales,





aSister, bConsanguineous parents; NA not available, Yr(s) year(s), mo(s) month(s), PP palmoplantar involvement; (+) hyperlinearity; (++) mild/moderate keratoderma;
(+++) pronounced keratoderma. cDiagnosis based on histopathological/immunohistochemical/ultrastructural findings; dthe patient was adopted
















STS ID-47 NA M Yesa 17 yrs Brown scales - NA
ID-48 NA M Yesa 16 yrs Brown scales - NA
ID-49 1 yr M Yesb 8 yrs Brownish polygonal scales, sparing of
folds
- ARCI
ID-50 NA M NA 3 yrs NA NA NA
ID-51 NA M NA 10 yrs NA NA NA
ID-52 Birth,
collodion
M Yesa 5 mos Fine scales on the trunk and brownish on
the arms and legs, residue of collodion
membrane, PP (+)
Failure to thrive Undefined
ID-53 Birth M No 16 yrs Brownish scales on legs and arms, large
scales on the trunk, sparing of folds,
involvement of the scalp
- ARCI
ID-54 1 yr M No 18 mos Small and medium brownish scales,
sparing of folds
- X-linked
ID-55 3wks M Yesc 12 mos Medium scales and onychodystrophy,
PP (+)
- X-linked
ID-56 NA M NA 12 yrs Brown scales Learning disabilities NA
ID-57 Birth M No 1yr Brown scales Cystine calculi, behavioural
anomalies
NA
ID-58 Birth M No 6 yrs Small and medium brown scales, sparing
of antecubital and popliteal areas
Hyperactivity Ichthyosis vulgaris
ID-59 NA M No 3 yrs Brownish scales Autistic behaviour
and language delay
NA
aBrother; bMaternal grandfather and two maternal uncles; cMaternal uncle; NA: not available; Yr(s): year(s); mo(s): month(s); (wks) weeks; PP: palmoplantar
involvement; (+) hyperlinearity; (++) mild/moderate keratoderma; (+++) pronounced keratoderma. dDiagnosis based on
histopathological/immunohistochemical/ultrastructural findings
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the MiSeq® system without any additional processing.
Library preparation and sequencing runs have been
performed according to the manufacturer’s procedure.
A TSCA panel design has been generated to investigate
the genes involved in syndromic and non-syndromic
ichthyoses: all coding regions, exon-intron boundaries,
5’UTR and 3’UTR of all the genes. A panel of 1080 ampli-
cons, each of 425 bp was designed, with a total length of
266,754 bp. The total coverage obtained by DS across the
entire region of interest was 95 % with amplicons showing
scores in the range of 60 % – 100 %. Amplicons with a
score lower than 60 % were excluded from the TSCA
panel. The list of genes included in the panel is reported
in Additional file 1: Table S1. Genes associated with non-
syndromic ichthyosis and those associated with syndromic
ichthyosis were merged into a single panel to facilitate
laboratory procedures.
Data analysis
The MiSeq® system provides fully integrated on-instrument
data-analysis software. The MiSeq Reporter software per-
forms secondary analysis on the base calls and quality
scores generated by Real Time Analysis (RTA) during the
sequencing run. The type of analysis performed is based on
the analysis workflow selected. The TruSeq Amplicon
workflow evaluates short regions of amplified DNA, or
amplicons, for variants. Focused sequencing of amplicons
enables high coverage of particular regions across a large
number of samples. The TruSeq Amplicon workflow per-
forms demultiplexing of indexed reads, generates FASTQ
files, aligns reads to a reference, identifies variants, and
writes output files to the Alignment folder. SNPs and short
indels are identified using the Genome Analysis Toolkit
(GATK). GATK calls raw variants for each sample, analyzes
variants against known variants, and then calculates a false
discovery rate for each variant. Each single variant has been
evaluated for the coverage and the Qscore, and visualized
via Amplicon Viewer (AV) and Integrative Genome Viewer
(IGV) software [6, 7]. The Qscore is the prediction of the
probability of an erroneous base call, in particular, a value
of Q30 represents the probability to call an erroneous base
out of 1000, reflecting an accuracy of the sequenced base
of 99.9 %. All detected variants have been filtered based on
their Qscore: only variants showing Qscore > 30 have been
considered in this study. Coverage for a defined amplicon
is the average number of sequencing reads representing a
given nucleotide in that amplicon. All mutations identi-
fied by Miseq Reporter were validated by Sanger se-
quencing or array Comparative Genomic Hybridization
(aCGH) in cases of genomic rearrangements, using
standard protocols.
Results
Sequencing data generated were evaluated on the basis of
the Qscore and coverage. As predicted by DS coverage in-
dication, the analysis confirmed the coverage of 95 % for
the panel. To achieve a full coverage of the whole target
regions, these ones were completed by conventional
Sanger sequencing.
As regards non-syndromic ichthyosis gene analysis we
have sequenced twenty regions by Sanger. For the
syndromic genes: ALDH3A2 and MBTPS2 were fully
covered by NGS analysis; PHYH, PEX7, SNAP29, AP1S1,
SPINK5 and EBP had only one region to be sequenced
by Sanger, while VPS33B six regions.
Each group of patients was investigated on the basis of
the clinicians and the pathologist information with a
specific diagnostic indication. Whenever discordance
with the genetic results was present, the case was care-
fully reconsidered in order to reach a correct diagnosis.
Tables 1, 2, 3 and 4 summarize personal data, family
history, clinical findings and histopathological/ultra-
structural diagnosis of our population.
In the group of ARCI, 27 out of 31 patients presented
genetic variants in different genes of the panel. Half of
them carried a homozygous mutation, ten were com-
pound heterozygotes while one patient had a hemizygous
mutation and a microdeletion on the other allele. Involve-
ment of ALOX12B was found in nine patients, TGM1 in
seven, NIPAL4 in four, ABCA12 in three, and ALOXE3

















KRT10 ID-61 Birth F NA 1 yr NA NA NA
ID-62 NA M NA 2 yrs Cutaneous erosions, hyperkeratosis
over the joints, PP (++)
- Keratinopathic ichthyosis
KRT2 ID-63 Birth F Yesb 27 yrs Diffuse hyperkeratosis, particularly
over the joints, few erosions, PP (+)
- Keratinopathic ichthyosis
ID-64 NA M NA 36yrs NA NA NA
aMother and grandmother; bdaughter; NA not available, Yr(s) year(s), mo(s) month(s), PP palmoplantar involvement; (+) hyperlinearity; (++) mild/moderate
keratoderma; (+++) pronounced keratoderma. cDiagnosis based on histopathological/immunohistochemical/ultrastructural findings
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Table 4 Clinicopathological findings of syndromic ichthyosis patient group
Target
gene






Dermatological features Extracutaneous findings Histopathology/Immunopathology/
Electron microscopyd
ALDH3A2 SLS ID-32 5 mos M Yes a,b 3 yrs Diffuse scaling, sparing of the face Psychomotor delay NA
ID-33 Birth M Yesa,b 10 yrs Ichthyosiform erythroderma Spastic paresis, psychomotor delay,
failure to thrive
NA
ID-34 Birth F Yesc,b 8 yrs Generalized scaling Spastic paresis, psychomotor delay NA
MBTPS2 IFAP ID-35 Birth M Nob 1 yr NA NA NA






CEDNIK ID-37 Birth M No NA NA NA NA
SPINK5 Netherton
syndrome
ID-38 Birth M No 6 mos Erythroderma, large thin scales,
sparse hair
Bilateral conjunctivitis Netherton syndrome
ID-39 Birth M No 2 yrs Erythroderma, large scales, fragile
and brittle hair
Failure to thrive Netherton syndrome
ID-40 Birth F NA 12 yrs NA NA NA
ID-41 Birth F No 4 mos Erythroderma and large scales NA NA
EBP Conradi Hünermann
Happle syndrome
ID-42 Birth F No 32 yrs NA Chondrodysplasia punctata NA
ID-43 Birth F No 3 mos NA Chondrodysplasia punctata NA




ABHD5 Neutral lipid storage
disease
ID-45 Birth M Yesa 17 yrs Erythroderma, fine whitish scales,





ID-46 Birth F Yesc 29 yrs Erythroderma, small whitish scales,
reticulated skin on joints, scales on the
scalp, PP (+++), mild ectropion
Hepatic cirrhosis, myopathy NA
aSister; bconsanguineous parents, cbrother; NA not available, Yr(s) year(s), mo(s) month(s), PP palmoplantar involvement; (+) hyperlinearity; (++) mild/moderate keratoderma; (+++) pronounced keratoderma. dDiagnosis
based on histopathological/immunohistochemical/ultrastructural findings















and CYP4F22 in two patients each. The vast majority of
mutations were missense (66.6 %), nonsense and splice
site mutations were quite equally represented (12.9 %
and 16.6 % respectively), while microdeletions and
frameshift mutations were more rare (1.8 %) (Table 5).
In the group of the X-linked ichthyosis thirteen individ-
uals were analyzed for the STS gene: three had a
missense mutation, eight had a genomic microdeletion
and two were negative (Table 6). Keratinopathic ichthy-
osis was analyzed in five subjects: one had a heterozy-
gous nonsense mutation in KRT1, in two a previously
described missense mutation in KRT10 was found, one
patient had a codon deletion in KRT2 while the last one
was negative (Table 7).
Syndromic ichthyoses include a broad group of
heterogeneous rare diseases with different incidence
and mutation rate. Among these we have collected
patients suspected for Netherton syndrome, Sjögren-
Larsson syndrome, Refsum syndrome, IFAP (ichthyosis
follicularis-alopecia-photophobia)/Bresheck syndrome,
Conradi-Hünermann-Happle syndrome, cerebral dysge
nesis-neuropathy-ichthyosis-palmoplantar keratoderma
syndrome (CEDNIK), mental retardation/enteropathy/
deafness/peripheral neuropathy/ichthyosis/keratoderma
Table 5 List of sequence variations detected in patients with ARCI and literature references
ARCI
Target Gene Sample ID Variation 1 Variation 2 Note and references
NIPAL4 ID-1 c.527 C > A, p.A176D c.527 C > A, p.A176D [10]
ID-2 c.527 C > A, p.A176D c.527 C > A, p.A176D [10]
ID-3 c.527 C > A, p.A176D c.527 C > A, p.A176D [10]
ID-4 c.527 C > A, p.A176D deletion [10]
ALOX12B ID-5 c.1594 G > C, p.E532Q c.130_131delGA, p.D44LfsX19 npd-npd
ID-6 c.1002delG, p.Q334HfsX18 c.1579 G > A, p.V527M npd - [11]
ID-7 c.1412 T > C, p.L471P c.1412 T > C, p.L471P npd
ID-8 c.1261 C > T, p.H421Y c.1261 C > T, p.H421Y [11]
ID-9 c.71 T > C, p.L24P c.1324 C > T, p.R442W npd - npd
ID-10 c.527 + 1G > A c.340 C > T, p.R114W npd - [12]
ID-11 c.1384G > A,p.G462S c.1384G > A,p.G462S Npd
ID-12 c.1192C > T,p.H398Y c.1192C > T,p.H398Y Npd
ID-13 c.1192C > T,p.H398Y c.1821 C > G, p.K607N npd – npd
CYP4F22 ID-14 c.728 g > a. p.R243H c.1084 C > T, p.R362X [13] - npd
ID-15 c.367 + 1G > A c.1303C > T, p.H435Y npd - [13]
TGM1 ID-16 c.814 T > C, p.S272P c.877-2 A > G [14, 15]
ID-17 c.877-2 A > G c.877-2 A > G [15]
ID-18 c.1187 G > A, p.R396H c.919 C > G, p.R307G [3–16]
ID-19 c.919C > G,p.R307G c.919C > G,p.R307G [16]
ID-20 c.788G > A,p.W263X c.788G > A,p.W263X [17]
ID-21 c.401A > G,p.Y134C c.401A > G,p.Y134C [3]
ID-22 c.1306C > G, p.H436D c.1306C > G, p.H436D npd - npd
ALOXE3 ID-23 c.1027C > T,p.R343X c.2285C > T,p.P762L npd - [12]
ID-24 c.543 + 5delG c.2461 C > T, p.R821W npd – npd
ABCA12 ID-25 c.7105-2delA c.7105-2delA Npd
ID-26 c.459T > G, p.Y153X c.4579 + 5 G > A npd – npd





npd not previously described, neg negative
Diociaiuti et al. Orphanet Journal of Rare Diseases  (2016) 11:4 Page 7 of 12
syndrome (MEDNIK), neutral lipid storage disease and
arthrogryposis-renal dysfunction-cholestasis (ARC)
syndrome in most of whom we have identified a genetic
defect (Table 8).
Discussion
The molecular diagnosis of ichthyosis is a complex and
articulate process that still represents an exciting chal-
lenge. Many resources and skills should be involved to
obtain satisfactory results. High-throughput technologies
can actually offer new opportunities in relation to the
amount of genes potentially analyzed, the number of
samples examined and the quality of results. NGS is an
innovative technology that is able to massive-parallel
sequence millions of DNA segments with high definition
capability. It has a wide diffusion in many fields of bio-
medical research, but diagnostic applications for genetic
diseases are still in progress. A previous study based on
NGS in a cohort of 14 patients affected by ichthyosis has
been published by Scott et al [8]. The authors underline
that NGS can be used as an accurate and cost-effective
tool in the molecular diagnosis of this group of diseases
with marked reduction in costs.
We report our experience on a cohort of patients
using a NGS approach on the Illumina MiSeq platform.
The preparation of the genomic library using the TSCA
Illumina kit was completed in two working days. Two
days were spent to run the samples on the MiSeq.
MiSeqReporter, AV and IGV2.3 software were used for
result interpretation. All mutations identified by Miseq
Reporter, were validated by Sanger sequencing using
standard protocols. 16 genes of different size were ana-
lyzed for the non-syndromic ichthyosis for each patient
in one experiment; the costs and the time of the analysis
are significantly reduced. Moreover the possibility to
analyze a large number of genes associated with various
diseases allows to study also the cases with not well
determined phenotypes, giving the opportunity to make
new genotype-phenotype correlation. Using this innova-
tive molecular approach we were able to find pathogenic
mutations in 53 out of 64 patients resulting in a 82.8 %
total detection rate. Moreover, considering the restricted,
more frequent group of ARCI, 27 out 31 patients had a
genetic diagnosis with an estimated detection rate of
87.1 %, corresponding to a higher sensitivity compared
to currently reported data [2].
Among ARCI we observed an unexpected high number
of 15 homozygous variants compared to the 18 compound
heterozygotes. Segregation analysis of family members
clarified that the significant frequency of homozygous
patients was due to several consanguineous marriages and
to some unrelated individuals belonging to restricted
geographic areas in relationship to a founder effect. Both
Table 6 List of mutations detected in patients with X-linked ichthyosis
X-Linked Ichthyosis
Target gene Sample ID Variation Note
STS ID-47 c.1075 G > A, p.G359R Npd
STS ID-48 c.1075 G > A, p.G359R Npd
STS ID-49 c.452 C > G, p.P151R Npd
STS ID-50 neg
STS ID-51 neg
STS ID-52 del ~1,5 Mb (6.552.712–8.115.153)
STS ID-53 del ~1,6 Mb (6.489.877–8.131.810)
STS ID-54 del ~1,5 Mb (6.552.712–8.097.511)
STS ID-55 del ~1,6 Mb (6.489.877–8.131.810)
STS ID-56 del ~1,6 Mb (6.467.006–8.131.810)
STS ID-57 del ~1,5 Mb (6.552.712–8.078.155)
STS ID-58 del ~1,5 Mb (6.552.712–8.097.511)
STS ID-59 del ~1,5 Mb (6.552.712–8.097.511)
npd not previously described, neg negative, del deleted
The field “Note” contains the start and the stop points of the genomic rearrangements
Table 7 List of sequence variations detected in patients with
keratinopathic ichthyosis and literature references
Keratinopathic ichthyosis
Target gene Sample ID Variation Note and
references
KRT1 ID-60 c.1657_1677del, p.S557_G563del [19]
KRT10 ID-61 c.466C > T, p.R156C [20]
KRT10 ID-62 c.467G > A, p.R156H [21]
KRT2 ID-63 c.561_563delCAA, p.N187del Npd
KRT2 ID-64 neg
npd not previously described, neg negative, del deleted
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Table 8 List of sequence variations detected in patients with syndromic ichthyosis and literature references
Syndromic Ichthyosis
Target gene Disease Sample ID Variation 1 Variation 2 Note and references
ALDH3A2 SLS ID-32 c.551 C > G, p.T184R c.551 C > G, p.T184R [22]
ID-33 c.680delG, p.R227fsX3 c.1108_1110delCTC, p.L370del npd - npd
ID-34 c.680delG, p.R227fsX3 c.1108_1110delCTC, p.L370del npd - npd
MBTPS2 IFAP ID-35 c.1286 G > A, p.R429H // [23]
PHYH Refsum syndrome ID-36 c.683_684insG, p.G228fsX2 c.683_684insG, p.G228fsX2 [24]
SNAP29-AP1S1 CEDNIK ID-37 neg
SPINK5 Netherton syndrome ID-38 c. 301 A > T, p.K101X ? Npd
ID-39 c.1732 C > T, p.R578X c.1888–1 G > A [25]
ID-40 c.1431–12 G > A c.1607 + 2 T > C [26] - npd
ID-41 neg
EBP CDPX2 ID-42 neg
ID-43 neg
VPS33B ARC ID-44 neg
ABHD5 Neutral lipid storage disease ID-45 c.550 C > T, p.R184X c.550 C > T, p.R184X [27]
ID-46 c.550 C > T, p.R184X c.550 C > T, p.R184X [27]
npd not previously described, neg negative, del deleted
SLS Sjögren-Larsson syndrome, IFAP Ichthyosis follicularis alopecia photophobia, CEDNIK Cerebral-dysgenesis-neuropathy-ichthyosis-palmoplantar keratoderma,
CDPX2 Conradi-Hünermann-Happle syndrome, ARC arthrogryposis-renal dysfunction-cholestasis syndrome
Fig. 1 Clinical and ultrastructural findings in a subgroup of patients with X-linked ichthyosis. Patient ID-58 presented brown scales, sparing of antecubital
and popliteal areas and normal palms and soles (a). Patient ID-52 showed residue of collodion membrane (b) and palmoplantar involvement (c). Electron
microscopy of ID-52 displayed hyperkeratosis without lipid drops or membranous structures, but only rare residues of melanosomes ((d), Uranyl
acetate-Lead citrate 3150x). Patient ID-49 presented brownish polygonal scales with sparing of folds (e), palms and soles (f)
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events seem to have a relevant role on the incidence of
ichthyosis in Italy. Another interesting result from the
analysis of the data is the high rate of novel sequence vari-
ations found compared to known mutations: about a half
of them were never reported in literature and their patho-
genic effect has been predicted from current data bases of
variants and from the familial study indicating both par-
ents as carriers.
In a subgroup of patients with X-linked ichthyosis dis-
crepancies were found between clinical features and
pathological observations. Patient ID-58 had been previ-
ously classified as vulgar ichthyosis on the basis of an
orthokeratotic hyperkeratosis, absence of granular layer
and reduced filaggrin staining. The child showed fine
brown scales, sparing of antecubital and popliteal areas
and normal palms and soles (Fig. 1a). Patient ID-52 was
born as a collodion baby and had a brother who had
been diagnosed with ichthyosis vulgaris. Once brought
to our attention, the patient still had a residue of collo-
dion membrane (Fig. 1b) and palmoplantar involvement
(Fig. 1c). Therefore, after an uninformative histological
and ultrastructural examination (Fig. 1d), he was placed
in ARCI group according to the clinical history. In pa-
tient ID-53 anomalies of keratinosomes were highlighted
in the ultrastructural study and lamellar ichthyosis was
suspected. On physical examination ichthyotic brownish
scales on legs and arms were observed together with
sparing of folds, involvement of the scalp and absence of
palmoplantar keratoderma.
Moreover, in patient ID-49 clinical history revealed
maternal grandfather and two of his brothers affected by
ichthyosis, giving evidence of an X-linked transmission,
while electron microscopy suggested an ARCI. Physical
examination showed brownish polygonal scales with
sparing of folds (Fig. 1e), palms and soles (Fig. 1f ).
In all these cases there were discrepancies between
clinical features and histology or electron microscopy
and only molecular analysis allowed to definitively re-
solve the diagnostic dilemma, demonstrating a deletion
or mutation in STS (Table 6). In particular Patient ID-
52, who was born as a collodion, shows that the age of
disease onset can no longer be considered a diagnostic
criterion, as already underlined by Oji V et al. [1].
Regarding the correlation between genotype and
phenotype the appearance of the palmoplantar area is
particularly interesting. As reported in literature, also in
our patients ichthyosis vulgaris is characterized by ac-
centuated markings, while X-linked usually is associated
with sparing of palms and soles (Fig. 1f ) [1, 9]. In the
group of ARCI, NIPAL4 mutation is associated with a
pronounced keratoderma (Fig. 2a), while ALOXE3 muta-
tion is associated with an ichthyosis vulgaris-like pattern
(Fig. 2b). ALOX12B and CYP4F22 mutations usually
produce moderate keratoderma (Fig. 2c).
The high number of patients enrolled in a relatively short
time (about one year) is the result of the collaboration with
the patient’s association and the Italian network of rare
diseases that identifies the reference centers on the
territory. Moreover, the activities on mutations analysis
were also publicized through national conferences and
publication on websites (www.ospedalebambinogesu.it,
www.orpha.net). This organization has allowed the diagno-
sis of extremely rare and severe forms of ichthyosis. There-
fore three patients affected by Sjögren-Larsson syndrome,
one by Refsum syndrome, two by Netherton syndrome,
one by IFAP/Bresheck syndrome and two by neutral lipid
storage disease were diagnosed. A third case of Netherton
syndrome had a partial molecular diagnosis because only a
single pathogenic mutation was found. We investigated
also the presence of haploinsufficiency but we were unable
to demonstrate any genomic rearrangement. In this
setting, the probability of a cryptic deep intronic variation
affecting splicing, according to the clinical features, could
be realistically taken into account.
Fig. 2 Palmar involvement in ARCI. Severe keratoderma in patient
ID-4 with NIPAL4 mutation (a). Patient ID-24 with ALOXE3 mutation
presented an ichthyosis vulgaris-like pattern (b). Patient ID-7 with
ALOX12B mutation showed a moderate keratoderma (c)
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Finally, the genetic diagnosis of ichthyosis leads to a
more accurate and effective genetic counseling, allowing
a correct evaluation of the risk of recurrence, particu-
larly in families with consanguineous background. On
this regard we have successfully managed several indi-
viduals, whose family members were affected from rare
life-threatening diseases, such as harlequin ichthyosis,
giving to the clinicians a needful tool to assess the repro-
ductive risk.
Conclusions
Our experience shows that the contribution to the diagno-
sis from anamnesis, physical examination, microscopy, and
laboratory examination is variable. Therefore, a careful
clinical selection of cases and a pathologic/clinical compari-
son are essential in order to guide the identification of the
genetic mutation that today represents the diagnostic gold
standard. In our experience this is underlined by the possi-
bility of having inconsistencies between the clinical appear-
ance and histopathology and by the detection in about half
the cases of new genetic variants that are not described in
the literature. Cases should be presented to the geneticist
with a precise clinicopathological diagnosis and the multi-
disciplinary approach is the best method to rule out extra-
cutaneous involvement and to improve the accuracy of the
diagnostic process.
Nowadays is available a new innovative technology,
NGS, that is more powerful, fast and economic and
allows to more easily obtain genetic diagnosis.
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